See every side of every news story
Published loading...Updated

Instylla receives FDA 510(k) clearance for Tembo embolic system - Interventional News

Summary by Interventional News
Tembo embolic system Instylla has announced the US Food and Drug Administration (FDA) 510(k) clearance of the Tembo embolic system. According to the company, Tembo is a bioresorbable embolization agent composed of irregularly shaped, dry-gelatine particles of a size range from 85 to 255µm. These particles are designed for the embolization of hypervascular tumours and blood vessels to occlude blood flow in the peripheral vasculature. “We hope tha…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Interventional News broke the news in on Friday, January 31, 2025.
Sources are mostly out of (0)